Cengild Medical Berhad
Cengild Medical Berhad, an investment holding company, operates a medical center in Malaysia. The company offers various care and treatment consultant services for gastrointestinal and liver diseases, morbid obesity, and oncology and urological conditions; general cardiology and gynecology assessment; gastroenterology and hepatology; anesthesiology, general surgery, internal medicine, and radiolo… Read more
Cengild Medical Berhad (0243) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of December 2025: 0.008x
Based on the latest financial reports, Cengild Medical Berhad (0243) has a cash flow conversion efficiency ratio of 0.008x as of December 2025.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (RM947.00K) by net assets (RM116.98 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Cengild Medical Berhad - Cash Flow Conversion Efficiency Trend (2020–2025)
This chart illustrates how Cengild Medical Berhad's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Cengild Medical Berhad Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Cengild Medical Berhad ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
YSX Tech. Co., Ltd Class A Ordinary Shares
NASDAQ:YSXT
|
-0.250x |
|
Opus One Resources Inc
V:OOR
|
0.000x |
|
Everpia Vietnam JSC
VN:EVE
|
N/A |
|
Health & Life Co., Ltd.
TWO:1781
|
-0.044x |
|
JR HOLDING SA BC ZY -10
F:8JA
|
N/A |
|
Thaire Life Assurance Public Company Limited
BK:THREL
|
0.026x |
|
Ajiya Bhd
KLSE:7609
|
-0.043x |
|
DESWELL INDS INC. DL-01
F:DW2
|
N/A |
Annual Cash Flow Conversion Efficiency for Cengild Medical Berhad (2020–2025)
The table below shows the annual cash flow conversion efficiency of Cengild Medical Berhad from 2020 to 2025.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-06-30 | RM114.46 Million | RM16.08 Million | 0.140x | +20.87% |
| 2024-06-30 | RM111.30 Million | RM12.94 Million | 0.116x | -10.39% |
| 2023-06-30 | RM106.11 Million | RM13.76 Million | 0.130x | -14.22% |
| 2022-06-30 | RM92.95 Million | RM14.05 Million | 0.151x | -85.43% |
| 2021-06-30 | RM13.78 Million | RM14.30 Million | 1.038x | -9.62% |
| 2020-06-30 | RM9.79 Million | RM11.24 Million | 1.148x | -- |